These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 9576366

  • 1. Intraperitoneal pulse calcitriol in the treatment of secondary hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis.
    Chan HW, Tsang WK, Chan CM, Fung SK, So SO, Tang HL, Tong MK, Lee KC, Chan AY.
    Perit Dial Int; 1998; 18(2):177-82. PubMed ID: 9576366
    [Abstract] [Full Text] [Related]

  • 2. Oral paricalcitol versus oral calcitriol in continuous ambulatory peritoneal dialysis patients with secondary hyperparathyroidism.
    Jamaluddin EJ, Gafor AH, Yean LC, Cader R, Mohd R, Kong NC, Shah SA.
    Clin Exp Nephrol; 2014 Jun; 18(3):507-14. PubMed ID: 23903802
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Calcium kinetic studies in patients on CAPD: improvement of secondary hyperparathyroidism without concomitant improvement of calcium turnover.
    Kurz P, Tsobanelis T, Brunkhorst R, Roth P, Werner E, Schoeppe W, Vlachojannis J.
    Perit Dial Int; 1997 Jun; 17(1):59-65. PubMed ID: 9068024
    [Abstract] [Full Text] [Related]

  • 5. Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group.
    Weinreich T, Ritz E, Passlick-Deetjen J.
    Perit Dial Int; 1996 Jun; 16(3):260-8. PubMed ID: 8761540
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Paricalcitol in dialysis patients with calcitriol-resistant secondary hyperparathyroidism.
    Llach F, Yudd M.
    Am J Kidney Dis; 2001 Nov; 38(5 Suppl 5):S45-50. PubMed ID: 11689387
    [Abstract] [Full Text] [Related]

  • 9. Limitations of pulse oral calcitriol therapy in continuous ambulatory peritoneal dialysis patients.
    Bechtel U, Mücke C, Feucht HE, Schiffl H, Sitter T, Held E.
    Am J Kidney Dis; 1995 Feb; 25(2):291-6. PubMed ID: 7847357
    [Abstract] [Full Text] [Related]

  • 10. Long-term effect of oral calcitriol single weekly pulse in CAPD and in HD.
    Romanini D, Gazo A, Bellazzi R, de Vincenzi A, Nai M, Santagostino M.
    Adv Perit Dial; 1994 Feb; 10():267-9. PubMed ID: 7999842
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 13. Hyperparathyroidism in CAPD patients: therapy with pulse oral calcitriol.
    Juergensen PH, Finkelstein FO, Cooper K, Santacroce S, Kliger AS.
    Adv Perit Dial; 1993 Nov; 9():257-9. PubMed ID: 8105938
    [Abstract] [Full Text] [Related]

  • 14. Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidism.
    Malberti F, Corradi B, Cosci P, Calliada F, Marcelli D, Imbasciati E.
    Am J Kidney Dis; 1996 Nov; 28(5):704-12. PubMed ID: 9158208
    [Abstract] [Full Text] [Related]

  • 15. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F, Corradi B, Imbasciati E.
    Adv Perit Dial; 1996 Nov; 12():239-44. PubMed ID: 8865912
    [Abstract] [Full Text] [Related]

  • 16. Effects of subcutaneous calcitriol administration on plasma calcium and parathyroid hormone concentrations in continuous ambulatory peritoneal dialysis uremic patients.
    Rolla D, Paoletti E, Marsano L, Mulas D, Peloso G, Cannella G.
    Perit Dial Int; 1993 Nov; 13(2):118-21. PubMed ID: 8494932
    [Abstract] [Full Text] [Related]

  • 17. Low-dose alfacalcidol controls secondary hyperparathyroidism in predialysis chronic kidney disease.
    Reichel H.
    Nephron Clin Pract; 2010 Nov; 114(4):c268-76. PubMed ID: 20090369
    [Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of pulse and daily calcitriol in patients on CAPD: a randomized trial.
    Moe SM, Kraus MA, Gassensmith CM, Fineberg NS, Gannon FH, Peacock M.
    Nephrol Dial Transplant; 1998 May; 13(5):1234-41. PubMed ID: 9623560
    [Abstract] [Full Text] [Related]

  • 19. Secondary hyperparathyroidism and risk factors in patients undergoing peritoneal dialysis in a tertiary hospital.
    Suwan N.
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S101-5. PubMed ID: 22043575
    [Abstract] [Full Text] [Related]

  • 20. High-dose oral calcitriol and zero calcium peritoneal solutions in CAPD patients with refractory secondary hyperparathyroidism.
    Malberti F, Scanziani R, Corradi B, Dozio B, Bonforte G, Imbasciati E, Surian M.
    Nephrol Dial Transplant; 1994 Sep; 9(12):1813-5. PubMed ID: 7708273
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.